CNTX Dividend History & Analysis | N/A Yield
CNTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| SIGA | 476 M | 10.4% | 12.6% |
| GS71 | 100,362 M | 4.18% | 6.87% |
| SAN | 115,079 M | 4.30% | 6.11% |
| SNY | 115,348 M | 4.43% | 5.67% |
| GSK | 99,334 M | 4.20% | 5.59% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| ZTS | 55,380 M | 18.9% | 100% |
| VIRP | 3,698 M | 17.9% | 82.1% |
| LLY | 974,789 M | 15.3% | 99.5% |
| BMY | 111,254 M | 14.0% | 92.6% |
| MRK | 66,503 M | 12.0% | 91.8% |
Quality Dividend Peers in Pharmaceuticals
6.08% Yield
3.70% Yield
3.02% Yield
3.68% Yield
1.34% Yield
2.08% Yield
CNTX Dividend History: as of January 2026
No dividends paid yet.CNTX Dividend FAQ
Context Therapeutics Inc. (NASDAQ:CNTX) is a U.S. biopharma focused on solid-tumor oncology, with its flagship candidate CTIM-76 – a bispecific antibody that links anti-Claudin 6 (CLDN6) to CD3 to direct T-cell cytotoxicity against CLDN6-positive cancer cells. The firm’s development pipeline is anchored by a collaboration with Integral Molecular, which supplies the CLDN6 bispecific monoclonal antibody platform. Context was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
What is the Dividend Yield of CNTX?
As of January 2026, CNTX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 2.47.Does CNTX pay a dividend?
As of January 2026 CNTX does not pay a dividend.How often does CNTX pay dividends?
Over the last 12 months, CNTX has issued dividend payments.CNTX dividend forecast
Based on historical data, the forecasted dividends per share for CNTX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will CNTX pay dividends in 2026?
The next Ex-Dividend date for Context Therapeutics (CNTX) is currently unknown.What is the next Ex-Dividend Date for CNTX?
The next Ex-Dividend date for Context Therapeutics (CNTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CNTX?
CNTX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CNTX?
CNTX's 5-Year Yield on Cost is -%. If you bought CNTX's shares at 5.10 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CNTX?
CNTX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CNTX have a good Dividend Yield?
CNTX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CNTX?
The Dividend Payout Ratio of CNTX is unknown.What is the Dividend Rating of CNTX?
CNTX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-24 02:38